ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Blood study insight could improve stem cell therapy success – Medical Xpress

Continue reading

2017-05-12 Michael Zand NEWS

A lead candidate for immunotherapy may increase tumour growth in certain cancers – Medical Xpress

Medical XpressA lead candidate for immunotherapy may increase tumour growth in certain cancersMedical XpressThe researchers believe this could have implications for the effectiveness of immunotherapy in combating human cancers caused by inflammation, s… Continue reading

2017-05-12 Michael Zand NEWS

Gene Therapy Advanced by Structural Study of Potential Viral Vectors – Genetic Engineering & Biotechnology News


Chaffee County Times

Blood study insight could improve stem cell therapy success
Medical Xpress
Researchers have pinpointed a key enzyme that is vital for the production of fresh blood cells in the body. The enzyme is essential for the survival of specialised stem cells that give rise to new blood cells, the study found. Experts say the findings …
Stop MS: Buena Vista’s Chris Martin set to try cutting-edge stem cell programChaffee County Times
Global $53 Billion Regenerative Medicine Market Analysis & Forecast Report 2017-2021: Focus on Stem Cells, Tissue …GlobeNewswire (press release)

all 3 news articles »

Continue reading

2017-05-12 Michael Zand NEWS

Is the US military in danger of using synthetic biology to ‘weaponize the environment’? – Genetic Literacy Project


Genetic Engineering & Biotechnology News

Gene Therapy Advanced by Structural Study of Potential Viral Vectors
Genetic Engineering & Biotechnology News
Scientists led by Associate Professor Vijay Reddy, Ph.D., at The Scripps Research Institute (TSRI) say they have discovered the structural details that make one virus a better tool for future therapies than a closely related virus. The team wrote in …

and more »

Continue reading

2017-05-12 Michael Zand NEWS

Abeona Therapeutics (ABEO) Announces Updated Data from Gene Therapy Trial for Sanfilippo Syndrome Type A at … – StreetInsider.com

Abeona Therapeutics (ABEO) Announces Updated Data from Gene Therapy Trial for Sanfilippo Syndrome Type A at …StreetInsider.comAbeona Therapeutics Inc. (NASDAQ: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene… Continue reading

2017-05-12 Michael Zand NEWS

The week that turned the cancer immunotherapy market on its head – pharmaphorum


Genetic Literacy Project

Is the US military in danger of using synthetic biology to ‘weaponize the environment’?
Genetic Literacy Project
… amount of money in these technologies as DARPA? The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: DARPA’s Synthetic Biology Initiatives Could Militarize the …

Continue reading

2017-05-12 Michael Zand NEWS

Stem Cell Vaccine Enhances Immune Response Against Tumors – Technology Networks

Technology NetworksStem Cell Vaccine Enhances Immune Response Against TumorsTechnology NetworksResearchers at the University of Cincinnati (UC) have found that a cancer stem cell vaccine, engineered to express a pro-inflammatory protein called interleu… Continue reading

2017-05-12 Michael Zand NEWS

Stem Cell Vaccine Enhances Immune Response Against Tumors – Technology Networks

Technology NetworksStem Cell Vaccine Enhances Immune Response Against TumorsTechnology NetworksResearchers at the University of Cincinnati (UC) have found that a cancer stem cell vaccine, engineered to express a pro-inflammatory protein called interleu… Continue reading

2017-05-12 Michael Zand NEWS
  • 1
  • …
  • 1,736
  • 1,737
  • 1,738
  • 1,739
  • 1,740
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

pharmaphorum

The week that turned the cancer immunotherapy market on its head
pharmaphorum
This week may have produced a seismic shift in cancer immunotherapy as serious doubts emerged about Roche’s main contender, while solid phase 3 results boosted investor confidence in a late-to-market rival from AstraZeneca. Just days after a late-stage …
AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What’s NextForbes
Key AstraZeneca drug shown to reduce risk of death from lung cancerKFGO
FTSE 100 boosted by AstraZeneca riseBBC News
Financial Times –Nasdaq –Citywire.co.uk
all 55 news articles »